Literature DB >> 19625769

The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer.

Jeffrey M Friedman, Peter A Jones, Gangning Liang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19625769      PMCID： PMC2846299          DOI： 10.4161/cc.8.15.9168

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

Review 1.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

Authors:  Andrei Kuzmichev; Raphael Margueron; Alejandro Vaquero; Tanja S Preissner; Michael Scher; Antonis Kirmizis; Xuesong Ouyang; Neil Brockdorff; Cory Abate-Shen; Peggy Farnham; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

3.  Epigenetic stem cell signature in cancer.

Authors:  Martin Widschwendter; Heidi Fiegl; Daniel Egle; Elisabeth Mueller-Holzner; Gilbert Spizzo; Christian Marth; Daniel J Weisenberger; Mihaela Campan; Joanne Young; Ian Jacobs; Peter W Laird
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

Review 4.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

5.  Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.

Authors:  Einav Nili Gal-Yam; Gerda Egger; Leo Iniguez; Heather Holster; Steingrímur Einarsson; Xinmin Zhang; Joy C Lin; Gangning Liang; Peter A Jones; Amos Tanay
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

6.  The polycomb group protein EZH2 is involved in progression of prostate cancer.

Authors:  Sooryanarayana Varambally; Saravana M Dhanasekaran; Ming Zhou; Terrence R Barrette; Chandan Kumar-Sinha; Martin G Sanda; Debashis Ghosh; Kenneth J Pienta; Richard G A B Sewalt; Arie P Otte; Mark A Rubin; Arul M Chinnaiyan
Journal:  Nature       Date:  2002-10-10       Impact factor: 49.962

7.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome.

Authors:  Jindan Yu; Jianjun Yu; Daniel R Rhodes; Scott A Tomlins; Xuhong Cao; Guoan Chen; Rohit Mehra; Xiaoju Wang; Debashis Ghosh; Rajal B Shah; Sooryanarayana Varambally; Kenneth J Pienta; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.

Authors:  Yutaka Kondo; Lanlan Shen; Alfred S Cheng; Saira Ahmed; Yanis Boumber; Chantale Charo; Tadanori Yamochi; Takeshi Urano; Koichi Furukawa; Bernard Kwabi-Addo; David L Gold; Yoshitaka Sekido; Tim Hui-Ming Huang; Jean-Pierre J Issa
Journal:  Nat Genet       Date:  2008-05-18       Impact factor: 38.330

9.  MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

Authors:  Hang Su; Jian-Rong Yang; Teng Xu; Jun Huang; Li Xu; Yunfei Yuan; Shi-Mei Zhuang
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

10.  The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2.

Authors:  Jeffrey M Friedman; Gangning Liang; Chun-Chi Liu; Erika M Wolff; Yvonne C Tsai; Wei Ye; Xianghong Zhou; Peter A Jones
Journal:  Cancer Res       Date:  2009-03-03       Impact factor: 12.701
View more
  19 in total

Review 1.  Epigenetic mechanisms in inflammation.

Authors:  D Bayarsaihan
Journal:  J Dent Res       Date:  2011-01       Impact factor: 6.116

2.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells.

Authors:  Murielle M Akpa; Diana Iglesias; LeeLee Chu; Antonin Thiébaut; Ida Jentoft; Leah Hammond; Elena Torban; Paul R Goodyer
Journal:  J Biol Chem       Date:  2015-12-10       Impact factor: 5.157

5.  Creating a flexible multiple microRNA expression vector by linking precursor microRNAs.

Authors:  Xiangning Qiu; Jeffrey M Friedman; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-24       Impact factor: 3.575

Review 6.  Linking epithelial-to-mesenchymal-transition and epigenetic modifications.

Authors:  Sonja C Stadler; C David Allis
Journal:  Semin Cancer Biol       Date:  2012-06-15       Impact factor: 15.707

7.  Can genes modify stroke outcome and by what mechanisms?

Authors:  Roger P Simon; Robert Meller; An Zhou; David Henshall
Journal:  Stroke       Date:  2011-12-08       Impact factor: 7.914

Review 8.  Role of ART in imprinting disorders.

Authors:  Ali Eroglu; Lawrence C Layman
Journal:  Semin Reprod Med       Date:  2012-04-27       Impact factor: 1.303

Review 9.  Epigenetic modulation of gene expression governs the brain's response to injury.

Authors:  Roger P Simon
Journal:  Neurosci Lett       Date:  2015-12-29       Impact factor: 3.046

10.  MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.

Authors:  Ying Wang; Xiushan Zheng; Zhiyong Zhang; Jinfeng Zhou; Guohong Zhao; Jianjun Yang; Limin Xia; Rui Wang; Xiqiang Cai; Hao Hu; Cailin Zhu; Yongzhan Nie; Kaichun Wu; Dexin Zhang; Daiming Fan
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.